HOLX vs RELIW · P/E 32, rev $4.10B vs rev $14.1M
Hologic Inc (HOLX) versus Reliance Global Group Inc (RELIW) — a side-by-side from cached financials, not a winner call.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Reliance Global Group Inc (RELIW) common stock listed on NASDAQ.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Latest reported RELIW revenue for 2024-12-31 was $14.1M. Net income was -$9.1M. Revenue was up 2.3% from 2023-12-31 to 2024-12-31. RELIW currently screens at market cap $39.2M.
HOLX currently screens at market cap $16.97B and trailing P/E 31.5. RELIW currently screens at market cap $39.2M.
Not investment advice. Open the HOLX and RELIW stock pages for the full models.
Not investment advice.